LE
Lexaria Bioscience Corp.
LEXXW · NASDAQ
$0.01 +31.87% (+$0.00)
Market Cap $201.2K
P/E Ratio -
Div. Yield -
ROE 149.35%
Bulios Fair Price
$0
100.0% downside
Trenutna cena
$0.012
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LEXXW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.04x
P/S 0.33x
PEG N/A
Growth
13 /100
Declining Book val. growth 6.43%
Rev. growth 10.43%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 1,586.10%
Op. margin 1,850.10%
Gross margin 99.56%
Quality
1 /100
Poor Asset turnover 0.09x
ROA 168.97%
ROIC 215.76%
Debt
100 /100
Low Current ratio 3.90x
Net debt/EBITDA 0.40x
Debt/Equity 0.02x
Stability
28 /100
Unstable Profitable years 0
EPS volatility 36.56%
Beta 0.37x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LEXXW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard C. Christopher
Employees
7
Headquarters
Kelowna